Amenorrhea

U.S. FDA Approves Oral Progesterone Prometrium

Published in Women's Health Weekly, June 1st, 1998

Solvay Pharmaceuticals, Inc., announced that the United States Food and Drug Administration (FDA) has approved the company's Prometrium^R (Progesterone, USP) Capsules for the treatment of secondary amenorrhea.

Prometrium is the first oral dosage form of micronized progesterone. It is synthesized from yams and is structurally identical to the natural progesterone found in a woman's body. Micronization increases the absorption of progesterone. Micronized progesterone was used in the National Institutes of Health-sponsored PEPI (Post-menopausal Estrogen/Progestin Intervention) study. PEPI was a three-year, multicenter, double-blind, placebo-controlled trial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry